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Skeletal muscle repair can be understood as a balance between ﬁbrosis and regeneration, the result of
which may lead to complete recovery or loss of muscle function. To study the involvement of nitric oxide
in post-trauma muscle repair, we used an experimental murine model of crush injury muscle. The
animals were divided into four groups, (i) control (CO), (ii) sham trauma, (iii) trauma and (iv) trau-
ma + L-NAME. The animals received a single dose of 100 mg/kg of the L-NAME, an inhibitor of nitric oxide
synthase, 2 h after lesion, and the muscle tissue was analyzed in two time-points: 24 h and 7 days.
Twenty-four hours after injury, the crushed muscle was characterized by an intense inﬂammatory cell
inﬁltrate and edema demonstrated by histological analysis. These changes were accompanied by
increased iNOS, MMP-2 and HGF mRNA transcription and protein expression of the iNOS and MMP-2
in the gastrocnemius muscle. Crushing injury also promoted cell proliferation and increase number satel-
lite cell, responsible for the regeneration of the muscle ﬁber. Treatment with L-NAME blocking local NO
production, greatly attenuated these histological and molecular ﬁndings at 24 h. On the 7th day the
molecular ﬁndings of both groups were comparable to the control (sham trauma) group. However, the
L-NAME group showed increase deposition of collagen and decrease of SC expression. These ﬁndings
demonstrate that activation of NO during muscle crush is critical in the early phases of the skeletal mus-
cle repair process and indicate its possible role as a regulator of the balance between ﬁbrosis and muscle
regeneration.
 2010 Elsevier Inc. Open access under the Elsevier OA license.Introduction ﬁbrotic scar tissue formation, resulting in better muscle functionalSkeletal muscle satellite cells (SC) are resident myogenic stem
cells normally found in a quiescent state in adult skeletal muscles.
These cells are mononuclear progenitor cells found in mature mus-
cle between the basal lamina and sarcolemma [1–3]. On activation,
they enter the cell cycle, divide, differentiate and fuse with muscle
ﬁbers to repair damaged regions after injuries [4]. The control
mechanisms of this sequential process are not well deﬁned,
although it has been reported that mechanical changes in muscle
can initiate events that lead to SC activation, such as a disruption
of the integrity of the sarcolemma and basal lamina [5]. Several
cytokines and inﬂammatory mediators, such as nitric oxide (NO)
released by local or inﬁltrating cells may also play a role [6]. Prob-
ably there is a complex combination of these multiple events. It
would be clinically important to be able to manipulate these
processes in order to improve muscle regeneration and minimizeumatologia do Hospital de
6 andar/sala645-90035-003
vier).
r OA license.recovery after injury.
During a crushing injury of the muscle ﬁbers, macrophages
invade the area of injury, phagocytose the necrotic tissue and
produce some growth factors that are mitogenic for muscle precur-
sor cells, such as ﬁbroblast growth factor (FGF), transforming
growth factor (TGF-b, interleukin-6), and hepatocyte growth factor
(HGF) [2,7,8]. HGF has been recently well studied as an activator of
SC. It is a a–b heterodimer produced by proteolytic cleavage of a
single-chain inactive precursor of 728 amino acids, localized in
the extracellular domain of uninjured skeletal muscle ﬁbers, at-
tached to the extracellular matrix [9–11].
The role of NO in the release of HGF from the extracellular ma-
trix has been investigated. Tatsumi et al. [12] studied the effects of
administration of L-NAME, an inhibitor of NOS function, or
D-NAME, an inactive stereoisomer, before a stretching stimulus to
the muscle. In vivo activation of SC and HGF release in stretched
muscle was inhibited by L-NAME, but not by D-NAME, indicating
that these processes are dependent of local NO production.
The NO-dependent HGF-matrix release could be mediated by
matrix metalloproteinases (MMP), a large family of zinc-
dependent endopeptidases that are capable of degrading one or
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including MMP-2, -3, -7, and -9, are found in skeletal muscle
[4,14], possibly playing fundamental roles in muscle ﬁber growth
and repair by regulating the integrity and composition of extracel-
lular matrix [15]. Yamada et al. [4] demonstrated that MMP-2
mediates stretch-induced activation of skeletal muscle SC in a
NO-dependent manner. Results from this study also provide evi-
dence that NO-activated MMP2 may cause release of HGF from
the extracellular matrix and contribute to SC activation in vitro.
However, in vitro model using single cell cultures may only permit
the study of the second stage of satellite cell activation and there
are no studies in vivo conﬁrming these observations.
This study explored the role of NO during repair process in an
experimental murine model of skeletal muscle injury using an
NO synthase inhibitor (nitro-L-arginine methyl ester: L-NAME),
with attention to MMP, HGF, SC and total cell proliferation.Materials and methods
Animals and experimental groups
Male Wistar rats weighing 250–300 g were used. The animals
were caged at 22 C, with 12-h light–dark cycles and free access
to food and water until the experiments were performed. All
experiments were performed according to the Guiding Principles
for Research Involving Animals (NAS) and the Committee of Re-
search and Ethics in Health of the Research and Postgraduate
Group of the Hospital de Clínicas de Porto Alegre.
Experimental animals were randomly divided into four groups
of twenty animals each: (i) C (control), (ii) ST (sham trauma +
L-NAME), (iii) T (trauma) and (iv) L-NAME (trauma + L-NAME). A
right gastrocnemius injury was induced by a single impact blunt
trauma with a press developed by the Centro Industrial de Equipa-
mentos de Ensino e Pesquisa Ltda (CIDEP/RS, Brazil), according to
the procedure of Lech [16]. Brieﬂy, injury was produced by a metal
mass (0.459 kg) falling through a metal guide from a height of
18 cm on the middle third of the gastrocnemius muscle belly.
The impact kinetic energy delivered was 0.811 J [17].
Experimental procedures
During the procedure, rats were anesthetized with a cocktail of
ketamine chlorhydrate (Ketalar, Parke Davis, 100 mg/kg) and 2%
xylazine (Rompun, Bayer, 50 mg/kg), administered i.p. Sham trau-
ma rats were also anesthetized to ensure standardization but did
not receive muscle trauma. Animals of the ST and L-NAME groups
received a 100 mg/kg dose of L-NAME i.p. 2 h post-trauma. Rats
were killed 24 h (10 animals each group) or 7 days (10 animals
each group) later for molecular and biochemical evaluation and
muscle histological analysis. The animals were anesthetized with
a cocktail of ketamine chlorhydrate and 2% xylazine i.p. The gas-
trocnemius muscle was rapidly removed from both legs, snap-
frozen in liquid nitrogen and stored at 80 C until analysis. The
entire surgical procedure took less than 10 min. The gastrocnemius
left paw was used as an internal control.
Histology
For histological examination, a section of muscle from each ani-
mal was trimmed and ﬁxed by immersion in 10% buffered formalin
for 24 h. The blocks were dehydrated in a graded series of ethanol
and embedded in parafﬁn wax. Serial 4-mm sections were stained
with hematoxylin and eosin or picrosirius. Five sections from each
sample were analyzed by two independent pathologists with no
prior knowledge of the animal groups.Morphometric image analysis
The collagen quantiﬁcation was realized by morphometric im-
age analysis through the speciﬁc software. Brieﬂy, from each sam-
ple, 10 images of the lesion area were captured from randomly
selected high-power ﬁelds (magniﬁcation, 100) measured by
the Adobe Photoshop CS3 Extended 10.0 (Adobe Systems Inc, San
Jose, CA) computer program and averaged to obtain the sample ﬁ-
nal value. The percentage of ﬁbrosis in each image was then calcu-
lated using the ratio of the ﬁbrosis area to the total amount of
pixels per image [18].
Real-time RT-PCR
Real-time PCR products were ampliﬁed on an Applied Biosys-
tems (Applied Biosystems, Weiterstadt, Germany) on an ABI PRISM
7000 sequence detection system using TaqMan-Gene Expression
Assays for HGF (GenBank accession No. D90102.1 and
Rn00566673_m1), iNOS (GenBank accession No. D12520.1 and
Rn00561646_m1), MMP-2 (GenBank accession No. U65656.1 and
Rn01538170_m1), and the housekeeping gene hypoxanthine phos-
phoribosyl-transferase (HPRT) (GenBank accession No. M63983.1
and Rn01527840_m1) were used. Relative changes in gene expres-
sion levels were determined using the 2DDCT method, as
described previously [19]. The cycle number at which the tran-
scripts were detectable (CT) was normalized to the cycle number
of HPRT detection, referred to as DCT.
Western blot analysis
For Western blot analysis of satellite cell (monoclonal anti-
PAX7; SIGMA–ALDRICH, St. Louis, MO), muscle homogenates were
prepared, after which protein concentration was measured using
the Bradford assay [19].
Immunohistochemical analysis
The slides were drained and incubated with anti-iNOS (SIGMA–
ALDRICH, St. Louis, MO), anti-MMP-2 (SIGMA–ALDRICH, St. Louis,
MO – 1:250), and anti-PCNA (Zymed, San Francisco, California,
USA – 1:1000), for 1 h at room temperature. Known positive and
negative tissue biopsies were used as observation controls.
Statistical analysis
Results are expressed as mean values with 95% conﬁdence
intervals (95%IC) for symmetric variables and as median and per-
centiles (25% and 75%) for asymmetric variables. The data were
compared by analysis of variance (ANOVA); when the analysis
indicated the presence of a signiﬁcant difference, the means were
compared using the Tukey test. Signiﬁcance was accepted at
p < 0.05. Values were analyzed using the statistical package SPSS
13.0 (SPSS, Inc., Chicago, IL).Results
Histological ﬁndings and morphometric image analysis
The sham group (untraumatized + L-NAME) animals showed
normal tissue architecture (Fig. 1A). At 24 h after trauma, there
was a loss of normal architecture, with clear inﬂammatory reaction
and edema (Fig. 1B). A single administration of the nitric oxide syn-
thase inhibitor L-NAME (100 mg/kg i.p. 2 h after the trauma) mark-
edly attenuated all the inﬂammatory histological abnormalities at
24 h (Fig. 1C). On the 7th day post-trauma there was distinct
Fig. 1. Histological analysis in muscle section in coloration of the hematoxylin–eosin and sirius red staining. (A) The sham trauma group (untraumatized + L-NAME) animals
showed normal architecture (HE – 100) (B) The trauma group (HE – 100) showed modiﬁcations of normal architecture, with edema and inﬂammatory reaction with
important inﬁltrate of neutrophils. (C) (HE – 100) the treatment with L-NAME decreased the inﬂammatory inﬁltrate. (D) The sham trauma group trauma group (sirius red –
100) in 7 days demonstrated normal architecture. (E) 7 days after muscle injury with fewer ﬁbrosis conﬁrmed in (H) in siruis red staining under polarized light (100). (F)
The L-NAME group (HE – 100) was associated with more intense and focal formation of ﬁbrotic tissue. (I) Important increase of the deposition of collagen (sirius red – 100)
under polarized light.
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centration in the trauma group (Fig. 1E). The administration of
L-NAME was associated with more intense and focal formation of
ﬁbrotic tissue (Fig. 1F). The collagen is refractile under polarized
light. Sirius red sections examined under polarized light demon-
strated higher collagen concentration in L-NAME group (Fig. 1H)
when compared with the trauma group (Fig. 1). The collagen quan-
tiﬁcation by morphometric image analysis demonstrated increased
collagen concentration in both trauma groups, as compared to the
control group, however, it was signiﬁcantly higher in L-NAME
group (801.3 ± 219 pixels) than in the trauma group (456.7 ± 88
pixels) (p < 0.05) with increased about 75% (Fig. 2).Fig. 2. Collagen quantiﬁcation by morphometric image analysis. The collagen
quantiﬁcation demonstrated increased collagen concentration in trauma group as
compared to the control group; however, it was signiﬁcantly higher in L-NAME
group.iNOS transcription and expression
Since L-NAME exposure appears to decrease the intensity of
acute inﬂammation, we evaluated its impact on iNOS tissue tran-
scription and expression. The trauma group demonstrated an in-
crease in the iNOS transcription (Table 1) and expression at 24 h
in the muscle ﬁber (Fig. 3B). On the order hand, L-NAME inhibited
the increase in the iNOSmRNA transcription by about 34% (Table 1)
and expression at 24 h (Fig. 3C). However, at 7 days both the trau-
ma and L-NAME treated groups did not present any detectable
iNOS transcription or expression (Table 2).Growth factors transcription and expression
We also studied the inﬂuence of L-NAME exposure in MMP-2
transcription and expression. This protein is involved in the
Table 1
Transcription mRNA of iNOS, MMP-2, and HGF markers in muscle injury rats in 24 h after lesion.
CO (n = 10) ST (n = 10) T (n = 10) L-NAME (n = 10)
iNOSa 100 (99.5–100.5) 174 (196–189) 1365.3 (1245.3–1485.3)* 366.5 (347.1–385.7)
MMP-2b 100 (99.4–100.6) 99 (92–100) 202.8 (181.8–223.8)* 167.4 (166.3–168.6)
HGFc 100 (98.6–101.4) 87 (75–100) 142.1 (124.3–159.8)* 69.04 (58.9–79.2)
Data were shown by mean ± 95%IC values.
CO = control group (n = 10).
ST = sham group (n = 10).
T = trauma group (n = 10).
L-NAME = L-NAME group (n = 10).
a Levels of iNOS mRNA normalized with HPRT as an endogenous reference.
b Levels of MMP-2 mRNA normalized with HPRT as an endogenous reference.
c Levels of HGF mRNA normalized with HPRT as an endogenous reference.
* p < 0.05 higher versus control and L-NAME groups.
Fig. 3. Immunohistochemistry of iNOS at 24 h after trauma. In photomicrography
(A) the sham trauma group (untraumatized + L-NAME) showed no expression
(immunohistochemistry – 200). (B) Trauma group (immunohistochemistry –
200) showed increase of iNOS expression in the cytoplasm of the muscle ﬁber. In
photomicrography (C) (immunohistochemistry – 200) the treatment with L-NAME
decrease iNOS expression.
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eling processes. There was no expression or transcription detected
in the sham trauma (untraumatized + L-NAME) animals (Table 1;
Fig. 4A). The trauma group presented moderate expression
(Fig. 4B) and an ampliﬁed transcription (Table 1) at 24 h. L-NAME
treated group had decreased transcription (Table 1) and similar
expression levels as the trauma group, but with a different expres-
sion pattern that was more restricted (Fig. 4C), with less positive
cells as compared to untreated mice. After 7 days, the transcription
decreased signiﬁcantly in both groups (Table 2), however, the cel-
lular expression was persistent in the trauma group and absent in
the L-NAME-treated group (Fig. 4D and E).
We analyzed the inﬂuence of L-NAME exposure in HGF tran-
scription. The trauma group presented an increase of the transcrip-tion at 24 h. Nevertheless, the L-NAME group showed decreased
transcription at 24 h (Table 1). There was no difference between
these groups after 7 days (Table 2).Total cell proliferation
We investigated the inﬂuence of L-NAME exposure on the local
cell proliferation of the injured muscle. The PCNA is a marker
widely used for cell proliferation, including satellite cell prolifera-
tion. In our study, the sham trauma group (untraumatized + L-
NAME) showed no expression of PCNA (Fig. 5A). The trauma group
demonstrated an increase in proliferation activity at the injury site
at 24 h after trauma (Fig. 5B). The administration of L-NAME de-
creased proliferative activity by about 34% at 24 h (Fig. 5C). After
7 days, both groups demonstrated similar cellular proliferation at
the injury site, which was still increased in relation to the control
group (Fig. 5D and E).Satellite cell expression
Finally, we studied the inﬂuence of L-NAME under the marker
molecule speciﬁc for satellite cells, the PAX-7. It is a member of
the paired box family of transcription factors, which is expressed
in cells residing beneath the basal lamina of muscle ﬁbers. The
trauma group demonstrated a higher positivity at 24 h after trau-
ma, while the administration of L-NAME signiﬁcantly inhibited this
increase in SC number. After 7 days, both groups demonstrated
similar levels of the PAX-7 expression (Fig. 6).Discussion
The importance of satellite cell activity in skeletal muscle
regeneration has been considered for some time. It is known that
muscle repair is initiated by mechanical or chemical stimuli, which
lead to the activation of quiescent satellite cells. On activation, they
enter the cell cycle, divide, differentiate and fuse with muscle ﬁ-
bers to repair damaged regions of muscle ﬁbers [4]. In our study,
the SC and total cell proliferation was analyzed by PAX-7 expres-
sion and anti-PCNA immunohistochemistry, respectively. Com-
pared to control, the trauma group exhibited increased SC
number and total cell proliferation at 24 h post-trauma. However,
a single administration of L-NAME, a NOS inhibitor, inhibited this
effect. These data, in conjunction with the ﬁndings of the histolog-
ical study (sirius red), where the L-NAME-treated showed greater
collagen concentration (Figs. 1 and 2) indicate that blocking NO
production in the early phases of muscle injury may tilt the
balance toward development of repair with ﬁbrotic scar tissue pro-
duction rather than muscle regeneration. Therefore, it is important
Table 2
Transcription mRNA of iNOS, MMP-2, and HGF markers in muscle injury rats in 7 days after lesion.
CO (n = 10) ST (n = 10) T (n = 10) L-NAME (n = 10)
iNOSa 100 (99.5–100.5) 74.4 (70.6–78.2) 61 (57–65) 73.1 (71.5–74.6)
MMP-2b 100 (99.3–100.6) 62.4 (45.2–79.6) 123 (107–139)* 137 (122–152)*
HGFc 100 (98.6–101.4) 83.7 (80–87.4) 111.9 (95.5–128.3) 89.5 (78.7–100.3)
Data were shown by mean ± 95%IC values.
CO = control group (n = 10).
ST = sham group (n = 10).
T = trauma group (n = 10).
L-NAME = L-NAME group (n = 10).
a Levels of iNOS mRNA normalized with HPRT as an endogenous reference.
b Levels of MMP-2 mRNA normalized with HPRT as an endogenous reference.
c Levels of HGF mRNA normalized with HPRT as an endogenous reference.
* p < 0.05 higher versus control.
Fig. 4. Immunohistochemistry of MMP-2 at 24 h and 7 days after trauma. In photomicrography (A) the sham trauma group (immunohistochemistry – 200) showed no
expression. In photomicrography (B) (immunohistochemistry – 200) the trauma group demonstrated moderate expression in 24 h. In (C) the treatment with L-NAME had
similar expression levels as the trauma group, but with a different expression pattern that was more restricted in 24 h after lesion. After 7 days the cellular expression was
persistent in the trauma group (photomicrography (D)) and absent in the group L-NAME-treated (photomicrography (E)).
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vation in trauma skeletal muscle.
Allen et al. [9] demonstrated that HGF could act as an activator
of quiescent SC in vitro. Regulation of HGF function in muscle can
occur at the transcriptional level and by its high-afﬁnity binding
to heparin sulfate proteoglycans of the tissue matrix.
Our experiments demonstrated in vivo that local transcription
of HGF was correlated to the NO synthesis (Table 1), with marked
inhibition when NO synthesis was blocked with L-NAME. Tatsumi
et al. [20], based in an in vitro experiment, has proposed that
mechanical stretch stimuli trigger an intracellular cascade of
events in the muscle ﬁbers, which is pH-dependent and involves
NOS activation, eventually leading to HGF release from the extra-
cellular compartment and subsequent SC activation. However,
there are controversial results on this topic. Wozniak and Anderson
[10] using the single-ﬁber culture model (normal andmdx) demon-
strated that both SC quiescence and activation are NO-dependent.
A possible candidate as the NO-dependent factor for HGF-
matrix release is the matrix metalloproteinase (MMP) [15].In the present study, we demonstrated that MMP-2 is being
transcripted and expressed in skeletal muscle 24 h after trauma
(Table 1 and Fig. 4) and that inhibition of NO production by
L-NAME was able to decrease this transcription and expression.
In parallel there was an increase in the deposition of collagen (sir-
ius red staining). Gosselin et al. [21] demonstrated intrinsic dissim-
ilarities in collagen metabolism between functionally different
skeletal muscles. Lewis et al. [22] hypothesized that differential
expression/activity of the gelatinases (MMP-2 and MMP-9) would
be observed during different phases of myoblasts to myotube for-
mation and that such expression had functional signiﬁcance.
Therefore, NO is a key signal responsible for SC activation and
HGF transcription and release after skeletal muscle injury [23].
As a limitation in our study, we have to acknowledge that the
information concerning iNOS, MMP-2 and PCNA is only semiquan-
titative, since no quantitative formal protein expression measure-
ment was performed. However, the immunohistochemical
analysis was done by two blinded pathologists, and the observa-
tions were clear-cut and highly correlated.
Fig. 5. Immunohistochemistry of PCNA at 24 h and 7 days after trauma. In photomicrography (A) the sham trauma group (immunohistochemistry – 400) showed no
expression. (B) the trauma group (immunohistochemistry – 400) showed moderate total cell proliferation at 24 h after trauma. In photomicrography (C)
(immunohistochemistry – 400) the treatment with L-NAME decreased the expression levels of total cell proliferation. After 7 days the cell proliferation was persistent
in both groups (photomicrography (D) and (E)).
Fig. 6. PAX-7 expression by Western blot analysis. (A) The image representative
blot of PAX-7 and the loading control of the b-actin. In graph (B) the PAX-7
expression demonstrated no expression in control and sham trauma groups at 24 h
and 7 days. The trauma group showed a higher positivity at 24 h after lesion; L-
NAME group inhibited this increase in SC number at 24 h. After 7 days, both groups
demonstrated similar levels of the PAX-7 expression.
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within the basal lamina is thought to stimulate synthesis of NO
by neuronal NOS located in association with the dystrophin–
glycoprotein complex beneath the sarcolemma; and endothelial
NOS located in muscle smooth [24]. Additionally, to the release
of nNOS and eNOS, there is production of iNOS by the local inﬂam-
matory process. In our experiments we demonstrated the overex-
pression of iNOS by RT-PCR and immunohistochemistry at 24 hafter trauma. Numerous studies have demonstrated increase iNOS
in inﬂammatory process [17,25]. Recently Tatsumi et al. [26] sug-
gested that calcium-calmodulin pathway may be involved in the
increased NO synthesis and resulting SC activation.
In summary, we presented in vivo data that support the notion
that the muscle regeneration process depends on initial NO pro-
duction, with subsequent matrix metalloproteinase activation, re-
lease of hepatocyte growth factor from the extracellular matrix,
increased total cell proliferation and increased of SC number.
Blocking early NO production, besides decreasing early cell prolif-
eration and SC activation, induced increased collagen deposition,
indicating that this molecule has an important role in the balance
of regeneration/ﬁbrosis during muscle repair process. Since regen-
eration is important for full functional recovery after muscle injury,
better comprehension of the diverse factors regulating this balance
may lead to innovative therapeutic approaches to muscle trauma.
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